Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Luminex

Biotech & Life Sciences · Austin, United States · Founded 1995 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Revenue
$500M–1B
Latest reported FY
Unlock exact value
Headcount
500–1k
Current team size
Unlock exact value

Patent intelligence

$161M patent portfolio · 75 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with topic prominence vs same-sector peers.

Estimated portfolio value
$161M
9.0% of valuation · 16.9× smaller than top peer Illumina ($2.7B)
75 active patent families
Where Luminex innovates BioinformaticsMolecular biologyNucleic acidBiologyOligonucleotide

Tech-focus vs peers

Where Luminex concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Luminex and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Luminex on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.